CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM

Abstract Background Aging is one of the important factor which regulates immunity. It is established in adolescence, whereas immunosenescence occurs in the old age. It is necessary to examine the changes in immune mechanisms during each period to consider what effects the immunity-decline in old age. Cannabinoid type 2 (CB2) receptor is known to be expressed throughout immune-related cells, and it has been reported to act as an inhibitory regulator of immune response. However, contribution of CB2 receptors to immunosenescence still remains unknown. Aims & Objectives This study focus on clarifying what CB2 signaling will do in context of systemic immune regulation from the perspective of age, by comprehensive analysis of immune cell behavior under presence or absence of CB2 activity. Methods We chose LPS-induced systemic inflammatory model to evoke immune activation. LPS (10 mg/kg) was given by i.p. to CB2-KO and WT controls of 5 different ages: 2 month-old to 6 month-old, one month apart. Spleen has been harvested from these mice 2 hours after the administration, and immunophenotyping by flow cytometry has been conducted. As a result, T/NKT and NK cell populations particularly increased in LPS-treated CB2-KO, whereas B cells and CD11chigh cell populations significantly decreased in same animals. Interestingly, such population change has only been seen in particular ages, which are between 2 and 4 months (Fig 1). This particular age range in mouse is equivalent to the 10s to 20s in human. Discussion & Conclusion Altogether, we found that CB2 signaling may affect LPS-mediated immune cell population change, particularly in specific age range that is young to mature adult. These results further suggest that CB2 signaling could be one of the key modulator of the immune system transition among age. Identification of the possibly-affected immune cells will be required, to confirm the detailed mechanism between CB2 activation and cell population fluctuations under aging.

Authors

Institutions

Publication Details

Journal
The International Journal of Neuropsychopharmacology
Published
2025-02-01
DOI
https://doi.org/10.1093/ijnp/pyae059.648
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM

Chihiro Nozaki, Toru Asahi, Haruka Hosoki
The International Journal of Neuropsychopharmacology
Diabetes and associated disorders
article

CB2 RECEPTOR IS ONE OF THE REGULATORY FACTORS OF THE AGE- RELATED CHANGES IN IMMUNE MECHANISM

Chihiro Nozaki, Toru Asahi, Haruka Hosoki
article en

Abstract

Abstract Background Aging is one of the important factor which regulates immunity. It is established in adolescence, whereas immunosenescence occurs in the old age. It is necessary to examine the changes in immune mechanisms during each period to consider what effects the immunity-decline in old age. Cannabinoid type 2 (CB2) receptor is known to be expressed throughout immune-related cells, and it has been reported to act as an inhibitory regulator of immune response. However, contribution of CB2 receptors to immunosenescence still remains unknown. Aims & Objectives This study focus on clarifying what CB2 signaling will do in context of systemic immune regulation from the perspective of age, by comprehensive analysis of immune cell behavior under presence or absence of CB2 activity. Methods We chose LPS-induced systemic inflammatory model to evoke immune activation. LPS (10 mg/kg) was given by i.p. to CB2-KO and WT controls of 5 different ages: 2 month-old to 6 month-old, one month apart. Spleen has been harvested from these mice 2 hours after the administration, and immunophenotyping by flow cytometry has been conducted. As a result, T/NKT and NK cell populations particularly increased in LPS-treated CB2-KO, whereas B cells and CD11chigh cell populations significantly decreased in same animals. Interestingly, such population change has only been seen in particular ages, which are between 2 and 4 months (Fig 1). This particular age range in mouse is equivalent to the 10s to 20s in human. Discussion & Conclusion Altogether, we found that CB2 signaling may affect LPS-mediated immune cell population change, particularly in specific age range that is young to mature adult. These results further suggest that CB2 signaling could be one of the key modulator of the immune system transition among age. Identification of the possibly-affected immune cells will be required, to confirm the detailed mechanism between CB2 activation and cell population fluctuations under aging.

The International Journal of NeuropsychopharmacologyVol. 28(Supplement_1)
Waseda University (JP)
Openalex Percentile: Top 97%
Diabetes and associated disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.